Advertisement

Hämatologische Aspekte arterieller Hypertonie

  • Anne Gould

Zusammenfassung

Verschiedene hämatologische Störungen stehen im Zusammenhang mit einer Hypertonie. Dazu gehören die Anämie bei einer malignen Hypertonie, Polyzythämie in Verbindung mit einer nicht-neoplastischen Erkrankung der Niere, wie z. B. Hydronephrose, polyzystische Nierenerkrankung, Nierenarterienstenose und die relative oder benigne Polyzythämie (bisweilen Gaisböck-Syndrom benannt). Das folgende Kapitel befaßt sich mit diesen Krankheitsbildern und den gebräuchlichen Methoden zu deren Behandlung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Babb AL, Popovich RP, Christopher TG, Scribner BH (1971) The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 17: 81PubMedGoogle Scholar
  2. 2.
    Baker LRI, Rubenberg ML, Dacie JV, Brain MC (1968) Fibrinogen catabolism in microangiopathic haemolytic anaemia. Br J Haematol 14: 617PubMedCrossRefGoogle Scholar
  3. 3.
    Baker LRI, Sevitt LH, Wrong OM (1969) Vascular lesions in malignant hypertension. Lancet 2: 593PubMedCrossRefGoogle Scholar
  4. 4.
    Berman LB (1973) Does renin stimulate the formation of erythropoietin? In: Sambhi MP (ed) Mechanisms of hypertension. American Elsevier New York, p 249Google Scholar
  5. 5.
    Bläker F, Altrogge H, Hellwege HH, Menke B, Thimm K (1978) Dialysebehandlung des schweren hämolytisch-urämischen Syndroms. Dtsch Med Wochenschr 103: 1229PubMedCrossRefGoogle Scholar
  6. 6.
    Blum AS, Zbar MJ (1959) Relative polycythemia. Alterations of red cell distribution simulating hemoconcentration. Arch Intern Med 104: 385PubMedCrossRefGoogle Scholar
  7. 7.
    Bourgoignie JJ, Gallagher NI, Perry HM, Kurz L, Warnecke MA, Donati RM (1968) Renin and erythropoietin in normotensive and in hypertensive patients. J Lab Clin Med 71: 523PubMedGoogle Scholar
  8. 8.
    Brain MC (1968) Haemolytic-uraemic syndrome. Lancet 2: 1394PubMedCrossRefGoogle Scholar
  9. 9.
    Brain MC, Dacie JV, Hourihane DOB (1962) Microangiopathic haemolytic anaemia: The possible role of vascular lesions in pathogenesis. Br J Haematol 8: 358PubMedCrossRefGoogle Scholar
  10. 10.
    Brown SM, Gilbert HS, Krauss S, Wassermann LR (1971) Spurious (relative) polycythemia: A nonexistent disease. Am J Med 50: 200PubMedCrossRefGoogle Scholar
  11. 11.
    Bull BS, Rubenberg ML, Dacie JV, Brain MC (1968) Microangiopathic haemolytic anaemia: Mechanisms of red cell fragmentation: in vitro studies. Br J Haematol 14: 643PubMedCrossRefGoogle Scholar
  12. 12.
    Capelli JP, Wesson LG jr, Erslev AV (1966) Malignant hypertension and red cell fragmentation syndrome. Ann Intern Med 64: 128PubMedGoogle Scholar
  13. 13.
    Chrysant SG, Frohlich ED, Adamopoulos PN, Stein PD, Whitcomb WH, Allen EW, Neller G (1976) Pathophysiologic significance of „stress“ or relative polycythemia in essential hypertension. Am J Cardiol 37: 1069PubMedCrossRefGoogle Scholar
  14. 14.
    Cooper RA (1970) The pathogenesis of burr cells in uremia. J Clin Invest 49: 22aGoogle Scholar
  15. 15.
    Cooper WM, Tuttle WB (1957) Polycythemia associated with a benign kidney lesion: Report of a case of erythrocytosis with hydronephrosis, with remission of polycythemia following nephrectomy. Ann Intern Med 47: 1008PubMedGoogle Scholar
  16. 16.
    Cunningham FG, Pritchard JA (1978) Hematologic considerations of pregnancy-induced hypertension. Semin Perinatol 2: 29PubMedGoogle Scholar
  17. 17.
    Dacie JV (1960) The haemolytic anaemias: congenital and acquired. Grune and Stratton New YorkGoogle Scholar
  18. 18.
    Davidson EC jr, Phillips LL (1972) Coagulation studies in the hypertensive toxemias of pregnancy. Am J Obstet Gynecol 113: 905PubMedGoogle Scholar
  19. 19.
    Eaton JW, Kolpin CF, Swofford HS, Kjellstrand C-M, Jacob HS (1973) Chlorinated urban water: A cause of dialysis-induced hemolytic anemia. Science 181: 463PubMedCrossRefGoogle Scholar
  20. 20.
    Ekberg M, Nilsson IM, Hedner U, Moqvist I, Bergentz S, Denneberg T (1974) Renal Anne Gould clusion, malignant hypertension and thrombotic thrombocytopenic purpura. Acta Med Scand 195: 499PubMedCrossRefGoogle Scholar
  21. 21.
    Emery AC jr, Whitcomb WH, Frohlich ED (1974) „Stress“ polycythemia and hypertension. JAMA 229: 159PubMedCrossRefGoogle Scholar
  22. 22.
    Erslev A (1969) Erythropoietic function of the kidney. In: Wesson LG jr (ed) Physiology of the human kidney. Grune and Stratton, New York, p 521Google Scholar
  23. 23.
    Eschbach JW jr, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA (1967) Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276: 653PubMedCrossRefGoogle Scholar
  24. 24.
    Fisher ER, Pardo V, Paul R, Hayashi TT (1969) Ultrastructural studies in hypertension: IV. Toxemia of pregnancy. Am J Pathol 55: 109PubMedGoogle Scholar
  25. 25.
    Fisher JW, Lertora JJL, Lindholm DD, Tornyos K, Moriyama Y (1973) Erythropoietin production and inhibitors in serum in the anemia of uremia. Proc Clin Cial Transplant Forum 3: 22Google Scholar
  26. 26.
    Gaisböck F (1905) Die Bedeutung der Blutdruckmessung für die ärztliche Praxis. Dtsch Arch Klin Med 83: 363Google Scholar
  27. 27.
    Gallagher NI, McCarthy JM, Lange RD (1960) Observations on erythropoietic-stimulating factor ( ESF) in the plasma of uremic and non-uremic patients. Ann Intern Med 52: 1201PubMedGoogle Scholar
  28. 28.
    Gardner FH, Freymann JG (1958) Erythrocythemia (polycythemia) and hydronephrosis: Report of a case with radio-iron studies, with recovery after nephrectomy. N Engl J Med 259: 323PubMedCrossRefGoogle Scholar
  29. 29.
    Gavras H, Brown WCB, Brown JJ, Lever AF, Linton AL, MacAdam RF, McNicol GP, Robertson JIS, Wardrop C (1971) Microangiopathic hemolytic anemia and the development of the malignant phase of hypertension. Circ Res [Suppl 2] 28 /29: 11–127Google Scholar
  30. 30.
    Gavras H. Oliver N, Aitchison J, Begg C, Briggs JD, Brown JJ, Horton PW, Lee F, Lever AF, Prentice C, Robertson JIS (1975) Abnormalities of coagulation and the development of malignant phase hypertension. Kidney Int 8: 252Google Scholar
  31. 31.
    Giesa J (1973) Renin, angiotensin and hypertensive vascular damage: A review. Am J Med 55: 315CrossRefGoogle Scholar
  32. 32.
    Gould AB, Goodman S, DeWolf R, Onesti G, Swartz C (1980) Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 96: 523PubMedGoogle Scholar
  33. 33.
    Hall CA (1965) Gaisböck’s disease: Redefinition of an old syndrome. Arch Intern Med 116: 4PubMedCrossRefGoogle Scholar
  34. 34.
    Hudgson P, Pearce JMS, Yeates WK (1967) Renal artery stenosis with hypertension and high haematocrit. Br Med J I: 18CrossRefGoogle Scholar
  35. 35.
    Isles C, Lowe GDO, Drummond MM, Forbes CD, Kennedy AC, Lever AF (1981) Blood rheology in malignant phase hypertension. Scand J clin Lab Invest 41, Suppl. 156: 175Google Scholar
  36. 36.
    Jones NF, Payne RW, Hyde RD, Price TML (1960) Renal polycythaemia. Lancet 1: 299PubMedCrossRefGoogle Scholar
  37. 37.
    Kaung DI, Peterson RE (1962) „Relative polycythemia“ or „pseudopolycythemia”. Arch Intern Med 110: 456PubMedCrossRefGoogle Scholar
  38. 38.
    Kincaid-Smith P (1972) Coagulation and renal disease. Kidney Int 2: 183PubMedCrossRefGoogle Scholar
  39. 39.
    Kincaid-Smith P, McMichael J, Murphy EA (1958) The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med 27: 117PubMedGoogle Scholar
  40. 40.
    Krauss S, Wasserman LR (1972) Spurious (relative) polycythemia. In: Williams WJ (ed) Hematology. McGraw-Hill, New York, p 555Google Scholar
  41. 41.
    Kurrle GR (1954) A case of Gaisböck’s disease (polycythaemia hypertonica). Med J Aust 1: 777Google Scholar
  42. 42.
    Lawrence JH, Berlin NI (1952) Relative polycythemia - the polycythemia of stress. Yale J Biol Med 24: 498PubMedGoogle Scholar
  43. 43.
    Lawrence JH, Donald WG (1959) Polycythemia and hydronephrosis or renal tumors. Ann Intern Med 50: 959PubMedGoogle Scholar
  44. 44.
    Lindholm DD, Pace RL, Russell HH jr (1969) Anemia of uremia responsive to increased dialysis treatment. Trans Am Soc Artif Intern Organs 15: 360PubMedGoogle Scholar
  45. 45.
    Linton AL, Gavras H, Gleadle RI, Hutchison HE, Lawson DH, Lever AF, MacAdam RF, McNicol GP, Robertson JIS (1969) Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. Lancet 1: 1277PubMedCrossRefGoogle Scholar
  46. 46.
    Luke RG, Kennedy AC, Stirling WB, McDonald GA (1965) Renal artery stenosis, hypertension and polycythaemia. Br Med J 1: 164PubMedCrossRefGoogle Scholar
  47. 47.
    Mann DL, Donati RM, Gallagher NI (1965) Erythropoietin assay and ferrokinetic measurements in anemic uremic patients. JAMA 194: 153CrossRefGoogle Scholar
  48. 48.
    Markson JL, Rennie JB (1956) The anaemia of chronic renal insufficiency. The effect of serum from azotaemic patients on the maturation of normoblasts in suspension cultures. Scott Med J 1: 320PubMedGoogle Scholar
  49. 49.
    Mel’nikov AF (1963) State of blood coagulation at different stages in arterial hypertension. Fed Proc [Trans Suppl] 22: T 74Google Scholar
  50. 50.
    Mirand EA, Murphy GP (1969) Erythropoietin alterations in patients with uremia, renal allo-grafts, or without kidneys. JAMA 209: 392PubMedCrossRefGoogle Scholar
  51. 51.
    Mitchell TR (1977) Diseases of the urinary system: Treatment of blood disorders in renal disease and renal failure. Br Med J II: 174Google Scholar
  52. 52.
    Neff MS, Kim KE, Persoff M, Onesti G, Swartz C (1971) Hemodynamics of uremic anemia. Circulation 43: 876PubMedCrossRefGoogle Scholar
  53. 53.
    Nixon RK, O’Rourke W, Rupe CE, Korst DR (1960) Nephrogenic polycythemia. Arch Intern Med 106: 797PubMedCrossRefGoogle Scholar
  54. 54.
    Raghupathy P, Date A, Shastry JCM, Sudarsanam A, Jadhav M (1978) Haemolytic-uraemic syndrome complicating shigella dysentery in south Indian children. Br Med J I: 1518Google Scholar
  55. 55.
    Regoeczi E, Rubenberg ML, Brain MC (1967) Intravascular haemolysis and disseminated intra-vascular coagulation. Lancet I: 601Google Scholar
  56. 56.
    Rubenberg ML, Regoeczi E, Bull BS, Dacie JV, Brain MC (1968) Microangiopathic haemolytic anaemia: the experimental production of haemolysis and red-cell fragmentation by defibrination in vivo. Br J Haematol 14: 627PubMedCrossRefGoogle Scholar
  57. 57.
    Russell RP, Conley CL (1961) Benign polycythemia: Gaisböck’s syndrome. Arch Intern Med 114: 734Google Scholar
  58. 58.
    Sevitt LH, Naish P, Baker LRI, Bulpitt CJ, Archer DFJ, Nelson DA, Peters DK (1973) The significance of microangiopathic haemolytic anaemia in accelerated hypertension. Br J Haematol 24: 503PubMedCrossRefGoogle Scholar
  59. 59.
    Stefanini M, Urbas JV, Urbas JE (1978) Gaisböck’s Syndrome: Its hematologic, biochemical and hormonal parameters. Angiology 29: 520Google Scholar
  60. 60.
    Stewart JH (1967) Haemolytic anaemia in acute and chronic renal failure. Q J Med 36: 85Google Scholar
  61. 61.
    Tarazi RC, Dustan HP, Frohlich ED, Gifford RW jr, Hoffman GC, (1970) Plasma volume and chronic hypertension. Arch Intern Med 125: 835PubMedCrossRefGoogle Scholar
  62. 62.
    Tarazi RC, Frohlich ED, Dustan HP, Gifford RW jr, Page IH (1966) Hypertension and high hematocrit: Another clue to renal arterial disease. Am J Cardiol 18: 855Google Scholar
  63. 63.
    Tibblin G, Bergentz S-E, Bjure J, Wilhelmsen L (1966) Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J 72: 165PubMedCrossRefGoogle Scholar
  64. 64.
    Ulrych M (1975) Erythrocytosis and renal-artery stenosis in transplants. Lancet: 867Google Scholar
  65. 65.
    Urbanyuk KG (1963) Prethrombotic tendency in arterial hypertension. Fed Proc (Trans Suppl) 22: T 76Google Scholar
  66. 66.
    von Hartitzsch B, Carr D, Kjellstrand C-M, Kerr DNS (1973) Normal red cell survival in well dialyzed patients. Trans Amer Soc Artif Int Organs 19: 471CrossRefGoogle Scholar
  67. 67.
    Wallner SF, Kurnick JE, Ward HP, Vautrin R, Alfrey AC (1976) The anemia of chronic renal failure and chronic diseases: In vitro studies of erythropoiesis. Blood 47: 561Google Scholar
  68. 68.
    Wallner SF, Vautrin RM (1981) Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med 97: 170PubMedGoogle Scholar
  69. 69.
    Wardle EN (1976) The functional role of intravascular coagulation in renal disease. Scott Med J 21: 83PubMedGoogle Scholar
  70. 70.
    Whitaker AN, Bunce I, Nicoll P, Dowling SV (1973) Interaction of angiotensin with disseminated intravascular coagulation: A possible mechanism in the genesis of acute renal failure. Am J Pathol 72: 1Google Scholar
  71. 71.
    Wilkinson R, Scott DF, Uldall PR, Kerr DNS, Swinney J (1970) Plasma renin and exchangeable sodium in the hypertension of chronic renal failure. Q J Med 39: 377PubMedGoogle Scholar
  72. 72.
    Wodzicki AM, Coopland AT (1977) Coagulation and the hypertensive diseases of pregnancy. Am J Obstet Gynecol 129: 393PubMedGoogle Scholar
  73. 73.
    Yawata Y, Howe R, Jacob HS (1973) Abnormal red cell metabolism causing hemolysis in uremia. A defect potentiated by tap water hemodialysis. Ann Intern Med 79: 362PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Anne Gould

There are no affiliations available

Personalised recommendations